packageTebentafusp

tebentafusp

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Tebentafusp is an anticancer medicine, a fusion protein, used to treat uveal melanoma (cancer of the eye). It is authorised in the European Union and is also being investigated for other uses.

Summary written by glm-5.3-flash from Wikidata Q110757700 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:tebentafusp
ATC codes:L01XX75
DrugBank:DB15283
Wikidata:Q110757700
molar mass:77000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown